3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects
Authors
Keywords
-
Journal
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
Volume 44, Issue 1, Pages 61-79
Publisher
Springer Nature
Online
2012-02-08
DOI
10.1007/s10863-012-9409-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic Targeting of Lactate Efflux by Malignant Glioma Inhibits Invasiveness and Induces Necrosis: An In Vivo Study
- (2015) Chaim B Colen et al. NEOPLASIA
- D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate
- (2011) S M El Sayed et al. CANCER GENE THERAPY
- Lactate Influx through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF- B/IL-8 Pathway that Drives Tumor Angiogenesis
- (2011) F. Vegran et al. CANCER RESEARCH
- Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin
- (2011) Lauren J. Akers et al. LEUKEMIA RESEARCH
- Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate
- (2011) E Babu et al. ONCOGENE
- Citric acid treatment of postoperative wound in an operated case of synovial sarcoma of the knee
- (2011) Basavraj S Nagoba et al. International Wound Journal
- Bioprocess development of the production of the mutant P-219-L human d-amino acid oxidase for high soluble fraction expression in recombinant Escherichia coli
- (2010) Rabab M. Abou El-Magd et al. BIOCHEMICAL ENGINEERING JOURNAL
- IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid
- (2010) Masahiko Yabu et al. INTERNATIONAL IMMUNOLOGY
- Potential cytotoxic effect of hydroxypyruvate produced from D-serine by astroglial D-amino acid oxidase
- (2010) S. P. Chung et al. JOURNAL OF BIOCHEMISTRY
- Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate
- (2009) Muthusamy Thangaraju et al. CANCER
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia
- (2009) RM Abou El-Magd et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Hypothesis proved…citric acid (citrate) does improve cancer: A case of a patient suffering from medullary thyroid cancer
- (2009) Alberto Halabe Bucay MEDICAL HYPOTHESES
- Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
- (2009) P. Dell'Antone Medicinal Chemistry
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate1
- (2008) Ana Paula Pereira Da Silva et al. BIOCHEMICAL JOURNAL
- Increased levels of superoxide and H2O2mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation
- (2008) Nùkhet Aykin-Burns et al. BIOCHEMICAL JOURNAL
- Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
- (2008) E. Hulleman et al. BLOOD
- Merlin Is a Potent Inhibitor of Glioma Growth
- (2008) Y.-K. I. Lau et al. CANCER RESEARCH
- 3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
- (2008) Linda Strandberg Ihrlund et al. Molecular Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started